🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China flag China · Delayed Price · Currency is CNY
19.59
-1.47 (-6.98%)
Nov 20, 2026, 3:04 PM CST

Hybio Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
17,30315,81011,38511,99415,52711,138
Market Cap Growth
2.40%38.87%-5.08%-22.75%39.41%88.22%
Enterprise Value
19,11617,61613,12213,71017,02412,784
Last Close Price
19.5917.9012.8913.5817.5812.61

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
44.54432.32---361.52
Forward PE
-9.219.219.219.219.21
PS Ratio
11.3416.3619.2927.8022.0515.13
PB Ratio
16.1525.1019.0715.3111.976.76
P/TBV Ratio
22.9445.0339.9222.3715.448.43
P/FCF Ratio
1172.07-232.96---
P/OCF Ratio
50.6667.5969.12-982.2871.02
PEG Ratio
-0.730.730.730.730.73

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
EV/Sales Ratio
12.5318.2322.2331.7824.1717.37
EV/EBITDA Ratio
32.4158.98114.07---
EV/EBIT Ratio
40.55104.65----
EV/FCF Ratio
1294.90-268.51---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Debt / Equity Ratio
1.853.033.012.591.391.09
Debt / EBITDA Ratio
3.406.3815.52---
Debt / FCF Ratio
135.78-36.79---
Net Debt / Equity Ratio
1.662.872.852.151.190.71
Net Debt / EBITDA Ratio
3.056.0514.80-7.57-29.27-8.09
Net Debt / FCF Ratio
121.85-4020.5134.83-19.76-8.85-27.80
Asset Turnover
0.430.310.190.130.190.19
Inventory Turnover
1.501.711.441.521.121.58
Quick Ratio
0.310.140.140.360.521.28
Current Ratio
0.620.290.330.480.711.55
Return on Equity (ROE)
45.60%5.55%-26.10%-49.56%-25.30%1.71%
Return on Assets (ROA)
8.28%3.42%-0.64%-6.74%-3.03%-4.26%
Return on Invested Capital (ROIC)
15.59%3.77%-1.36%-14.00%-6.44%-7.61%
Return on Capital Employed (ROCE)
21.90%12.30%-2.00%-20.00%-7.40%-8.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Earnings Yield
2.25%0.23%-1.52%-4.28%-2.39%0.28%
FCF Yield
0.09%-0.00%0.43%-0.71%-1.12%-0.38%
Payout Ratio
24.24%259.33%---375.37%
Buyback Yield / Dilution
-3.29%-5.29%2.00%-0.42%14.09%-11.21%
Total Shareholder Return
-3.29%-5.29%2.00%-0.42%14.09%-11.21%